US 10272075
Method and composition for treating an alpha adrenoceptor-mediated condition
granted A61KA61K31/145A61K31/445
Quick answer
US patent 10272075 (Method and composition for treating an alpha adrenoceptor-mediated condition) held by VANDA PHARMACEUTICALS INC. expires Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- VANDA PHARMACEUTICALS INC.
- Grant date
- Tue Apr 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/145, A61K31/445, A61K31/454, A61K31/473